Latest Kinaset Therapeutics News & Updates

See the latest news and media coverage for Kinaset. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Kinaset Therapeutics (Kinaset)

Biopharmaceutical company developing inhaled respiratory disease treatments

kinasettherapeutics.com
Headquarters
Boston, United States
Founded year
2020
Company type
Private company
Number of employees
10–16
Industry
Pharmaceuticals

Last updated

Latest news about Kinaset Therapeutics (Kinaset)

In short: Kinaset dosed the first patient in its Phase 2b severe-asthma trial and raised $103 million.

Company announcements

Kinaset

Kinaset launches with $40M Series A funding

The company also gains an exclusive global license to KN-002, an inhaled pan-JAK inhibitor for severe asthma, with a Phase 1/1b trial planned for 1H 2021.

Unlock all announcements with a

Media coverage

Business Wire

Kinaset Therapeutics Launches with a $40M Series A Financing to Develop Novel Therapeutics for Respiratory Diseases and an Exclusive Global License Agreement with Vectura Group for KN-002 (VR588), a Novel Anti-Inflammatory

Kinaset Therapeutics, Inc. (“Kinaset” or the “Company”), a newly-founded biopharmaceutical company, today announced a $40 million Series A financing with a b...

Unlock all articles with a

Never miss news about Kinaset

Track Kinaset and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.